Evidence map›Paper›PMID 25811392›Full record

ArticlePloS one2015

Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.

Federico Cividini, Maria Grazia Tozzi, Alvaro Galli, Rossana Pesi, Marcella Camici, Charles Dumontet, Lars Petter Jordheim, Simone Allegrini

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Emerging Role of Purine Metabolizing Enzymes in Brain Function and Tumors.International journal of molecular sciences · 2018
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Federico CividiniUniversity of Pisa, Department of Biology, Biochemistry Unit, Pisa, Italy.
Maria Grazia TozziUniversity of Pisa, Department of Biology, Biochemistry Unit, Pisa, Italy.
Alvaro GalliNational Research Counsil (CNR), Institute of Clinical Physiology, Pisa, Italy.
Rossana PesiUniversity of Pisa, Department of Biology, Biochemistry Unit, Pisa, Italy.
Marcella CamiciUniversity of Pisa, Department of Biology, Biochemistry Unit, Pisa, Italy.
Charles DumontetUniversité de Lyon, Lyon, France; Université de Lyon 1, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Lars Petter JordheimUniversité de Lyon, Lyon, France; Université de Lyon 1, Lyon, France; INSERM U1052, Centre de Recherche en Cancérologie de Lyon, Lyon, France; CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Simone AllegriniUniversity of Sassari, Department of Chemistry and Pharmacology, Sassari, Italy.
University of Pisa · ITCentre National de la Recherche Scientifique · FRIstituto di Fisiologia Clinica · ITUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IMP/GMP preferring cytosolic 5'-nucleotidase II (cN-II) is a bifunctional enzyme whose activities and expression play crucial roles in nucleotide pool maintenance, nucleotide-dependent pathways and programmed cell death. Alignment of primary amino acid sequences of cN-II from human and other organisms show a strong conservation throughout the entire vertebrata taxon suggesting a fundamental role in eukaryotic cells. With the aim to investigate the potential role of this homology in protein-protein interactions, a two hybrid system screening of cN-II interactors was performed in S. cerevisiae. Among the X positive hits, the Leucin Rich Repeat (LRR) domain of Ipaf was found to interact with cN-II. Recombinant Ipaf isoform B (lacking the Nucleotide Binding Domain) was used in an in vitro affinity chromatography assay confirming the interaction obtained in the screening. Moreover, co-immunoprecipitation with proteins from wild type Human Embryonic Kidney 293 T cells demonstrated that endogenous cN-II co-immunoprecipitated both with wild type Ipaf and its LRR domain after transfection with corresponding expression vectors, but not with Ipaf lacking the LRR domain. These results suggest that the interaction takes place through the LRR domain of Ipaf. In addition, a proximity ligation assay was performed in A549 lung carcinoma cells and in MDA-MB-231 breast cancer cells and showed a positive cytosolic signal, confirming that this interaction occurs in human cells. This is the first report of a protein-protein interaction involving cN-II, suggesting either novel functions or an additional level of regulation of this complex enzyme.

Indexed as

5'-NucleotidaseAnimalsCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCattleCell ExtractsCell Line, TumorHEK293 CellsHumansImmunoprecipitationLeucine-Rich Repeat ProteinsProtein BindingProteinsRecombinant ProteinsStructural Homology, ProteinTransfection5'-NucleotidaseCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsCell ExtractsLeucine-Rich Repeat ProteinsNLRC4 protein, humanNT5C2 protein, humanProteinsRecombinant Proteins

Identifiers

PMID25811392
PMCPMC4374842
OpenAlexW2071019860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.